Viewing Study NCT06383468


Ignite Creation Date: 2025-12-24 @ 5:31 PM
Ignite Modification Date: 2026-02-25 @ 6:35 PM
Study NCT ID: NCT06383468
Status: RECRUITING
Last Update Posted: 2024-04-25
First Post: 2024-04-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase III Study to Evaluate the Efficacy and Safety of AK120 in Patients With Moderate to Severe Atopic Dermatitis
Sponsor: Akeso
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module